New Market Study Published: Romania Pharmaceuticals & Healthcare Report Q3 2014
BMI View: Our above-consensus outlook for economic growth in Romania has borne out, with positive implications for the pharmaceutical sector. With wages set to rise and consumer spending continuing to grow at a rapid clip, consumer non-discretionary spending is set to tick higher. We see over-the-counter medicines and potentially generic medicines benefitting from an improving consumer picture. Over the longer term, Rom ania's competitive labour costs are set to catalyse an influx of manufacturing into the country, with positive implications...
View full press release